REPL

Replimune Group, Inc.CIK 1737953 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

$2.08M

10 trades · 4 insiders

Net · 90d

$-2.08M

Insiders on file

AI insights for REPL PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for REPL

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Astley-Sparke Philip	Executive Chairman	42	$0	$6.90M	2026-08-20
Hill Emily Luisa	Chief Financial Officer	17	$0	$761.6K	2026-08-17
BAKER BROS. ADVISORS LP	Director, 10% Owner	2	$33.00M	$0	2026-08-11
BAKER FELIX	Director, 10% Owner	2	$33.00M	$0	2026-08-11
Schwendenman Andrew	Chief Accounting Officer	12	$0	$279.4K	2026-08-10
Xynos Konstantinos	Chief Medical Officer	21	$0	$830.4K	2026-08-10
Patel Sushil	Chief Strategy Officer	24	$0	$2.35M	2026-08-10
Sarchi Christopher	Chief Commercial Officer	15	$0	$412.2K	2026-06-01
Peeples-Dyer Veleka	Director	4	$0	$0	2026-04-01
Oliger Christy J.	Director	6	$0	$0	2026-04-01
Weinand Dieter	Director	9	$0	$0	2026-04-01
Baker Bros. Advisors (GP) LLC	Director, 10% Owner	4	$0	$0	2026-04-01
Balachandran Madhavan	Director	3	$0	$0	2026-04-01
Dhingra Kapil	Director	17	$0	$1.86M	2026-04-01
Pucci Paolo	Director	7	$0	$0	2026-04-01
SLATTERY JOSEPH P	Director	13	$100.0K	$239.2K	2026-04-01
Love Colin	Chief Operating Officer	52	$0	$13.28M	2024-05-16
Coffin Robert	President and CEO	29	$0	$21.06M	2024-05-16
Levitsky Hyam	Director	7	$0	$0	2024-04-01
Esposito Pamela	Chief Business Officer	84	$0	$8.76M	2023-09-12
Lewis Tanya	Director	12	$0	$609.6K	2023-06-13
Franchi Jean M.	Chief Financial Officer	22	$0	$2.01M	2023-05-16
Slootweg Hugo Alexander	Director, 10% Owner	15	$2.00M	$0	2023-04-01
Rhodes Jason P	Director	81	$14.97M	$17.66M	2022-04-01
Omega Fund IV G.P. Manager, Ltd.	10% Owner	14	$0	$4.40M	2022-03-16
Omega Fund IV GP, L.P.	10% Owner	14	$0	$4.35M	2021-11-22
Stampacchia Otello	Director, 10% Owner	5	$2.99M	$920.4K	2021-09-23
Omega Fund IV, L.P.	Director, 10% Owner	3	$0	$3.30M	2021-09-17
Pirzkall Andrea	Chief Medical Officer	3	$0	$0	2021-04-01
Atlas Venture Fund X, L.P.	10% Owner	8	$0	$0	2020-09-15
GORGOL STEPHEN A	Chief Accounting Officer	3	$0	$0	2020-04-01
Kaufman Howard	Chief Medical Officer	4	$0	$0	2019-11-26
Forbion Capital Fund III Cooperatief U.A.	10% Owner	9	$2.00M	$0	2018-07-24
Bain Capital Life Sciences Investors, LLC	10% Owner	3	$7.50M	$0	2018-07-24
Green Jeremy	10% Owner	2	$0	$0	2018-07-24
Lim Richard J.	10% Owner	10	$4.00M	$0	2018-07-24

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Astley-Sparke Philip	Director	G Gift	2026-08-20	2026-08-24	50,000	—	$0	1,362,414	SEC↗
Astley-Sparke Philip	Director	G Gift	2026-08-20	2026-08-24	50,000	—	$0	1,362,414	SEC↗
Hill Emily Luisa	Chief Financial Officer	S Sale	2026-08-17	2026-08-19	9,256	$14.28	$132.2K	215,852	SEC↗
Hill Emily Luisa	Chief Financial Officer	S Sale	2026-08-17	2026-08-19	9,256	$14.28	$132.2K	215,852	SEC↗
BAKER FELIX	Director, 10% Owner	P Buy deriv	2026-08-11	2026-08-11	2,609,946	$12.06	$31.48M	2,609,946	SEC↗
BAKER FELIX	Director, 10% Owner	P Buy deriv	2026-08-11	2026-08-11	126,394	$12.06	$1.52M	126,394	SEC↗
BAKER BROS. ADVISORS LP	Director, 10% Owner	P Buy deriv	2026-08-11	2026-08-11	2,609,946	$12.06	$31.48M	2,609,946	SEC↗
BAKER BROS. ADVISORS LP	Director, 10% Owner	P Buy deriv	2026-08-11	2026-08-11	126,394	$12.06	$1.52M	126,394	SEC↗
Schwendenman Andrew	Chief Accounting Officer	S Sale	2026-08-10	2026-08-12	7,632	$12.97	$99.0K	99,425	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2026-08-10	2026-08-12	11,447	$12.97	$148.5K	224,215	SEC↗
Hill Emily Luisa	Chief Financial Officer	S Sale	2026-08-10	2026-08-12	11,448	$12.97	$148.5K	225,108	SEC↗
Patel Sushil	Chief Executive Officer	S Sale	2026-08-10	2026-08-12	39,341	$12.97	$510.3K	708,151	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2026-08-10	2026-08-12	11,447	$12.97	$148.5K	224,215	SEC↗
Schwendenman Andrew	Chief Accounting Officer	S Sale	2026-08-10	2026-08-12	7,632	$12.97	$99.0K	99,425	SEC↗
Patel Sushil	Chief Executive Officer, Dir	S Sale	2026-08-10	2026-08-12	39,341	$12.97	$510.3K	708,151	SEC↗
Hill Emily Luisa	Chief Financial Officer	S Sale	2026-08-10	2026-08-12	11,448	$12.97	$148.5K	225,108	SEC↗
Sarchi Christopher	Chief Commercial Officer	S Sale	2026-06-01	2026-06-03	12,000	$9.24	$110.9K	180,962	SEC↗
Hill Emily Luisa	Chief Financial Officer	S Sale	2026-05-18	2026-05-20	7,812	$5.08	$39.7K	236,556	SEC↗
Patel Sushil	Chief Executive Officer	S Sale	2026-05-18	2026-05-20	37,324	$5.08	$189.6K	747,492	SEC↗
Astley-Sparke Philip	Director	S Sale	2026-05-18	2026-05-20	17,657	$5.08	$89.7K	1,412,414	SEC↗
Sarchi Christopher	Chief Commercial Officer	S Sale	2026-05-18	2026-05-20	8,626	$5.08	$43.8K	192,962	SEC↗
Schwendenman Andrew	Chief Accounting Officer	S Sale	2026-05-18	2026-05-20	7,894	$5.08	$40.1K	107,057	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2026-05-18	2026-05-20	14,023	$5.08	$71.2K	235,662	SEC↗
Sarchi Christopher	Chief Commercial Officer	S Sale	2026-04-02	2026-04-06	6,500	$8.01	$52.1K	151,588	SEC↗
Weinand Dieter	Director	A Award deriv	2026-04-01	2026-04-07	44,500	—	$0	44,500	SEC↗
Hill Emily Luisa	Chief Financial Officer	A Award deriv	2026-04-01	2026-04-07	75,000	—	$0	75,000	SEC↗
Peeples-Dyer Veleka	Director	A Award deriv	2026-04-01	2026-04-07	44,500	—	$0	44,500	SEC↗
SLATTERY JOSEPH P	Director	A Award deriv	2026-04-01	2026-04-07	44,500	—	$0	44,500	SEC↗
Pucci Paolo	Director	A Award deriv	2026-04-01	2026-04-07	44,500	—	$0	44,500	SEC↗
Dhingra Kapil	Director	A Award deriv	2026-04-01	2026-04-07	44,500	—	$0	44,500	SEC↗
Patel Sushil	Chief Executive Officer	A Award deriv	2026-04-01	2026-04-07	376,860	—	$0	376,860	SEC↗
Schwendenman Andrew	Chief Accounting Officer	A Award deriv	2026-04-01	2026-04-07	55,000	—	$0	55,000	SEC↗
Balachandran Madhavan	Director	A Award deriv	2026-04-01	2026-04-07	44,500	—	$0	44,500	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award deriv	2026-04-01	2026-04-07	75,000	—	$0	75,000	SEC↗
Oliger Christy J.	Director	A Award deriv	2026-04-01	2026-04-07	44,500	—	$0	44,500	SEC↗
Astley-Sparke Philip	Director	A Award deriv	2026-04-01	2026-04-07	75,000	—	$0	75,000	SEC↗
Sarchi Christopher	Chief Commercial Officer	A Award deriv	2026-04-01	2026-04-07	75,000	—	$0	75,000	SEC↗
Baker Bros. Advisors (GP) LLC	Director, 10% Owner	A Award deriv	2026-04-01	2026-04-07	44,500	—	$0	44,500	SEC↗
Baker Bros. Advisors (GP) LLC	Director, 10% Owner	A Award deriv	2026-04-01	2026-04-07	44,500	—	$0	44,500	SEC↗
Hill Emily Luisa	Chief Financial Officer	A Award	2026-04-01	2026-04-07	50,000	—	$0	244,368	SEC↗
Patel Sushil	Chief Executive Officer	A Award	2026-04-01	2026-04-07	251,240	—	$0	784,816	SEC↗
Schwendenman Andrew	Chief Accounting Officer	A Award	2026-04-01	2026-04-07	36,667	—	$0	114,951	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award	2026-04-01	2026-04-07	50,000	—	$0	249,685	SEC↗
Astley-Sparke Philip	Director	A Award	2026-04-01	2026-04-07	50,000	—	$0	1,430,071	SEC↗
Sarchi Christopher	Chief Commercial Officer	A Award	2026-04-01	2026-04-07	50,000	—	$0	201,588	SEC↗
Astley-Sparke Philip	Director	G Gift	2026-02-18	2026-02-20	25,000	—	$0	1,380,071	SEC↗
Schwendenman Andrew	Chief Accounting Officer	A Award	2025-12-19	2025-12-19	10,000	—	$0	78,284	SEC↗
Sarchi Christopher	Chief Commercial Officer	A Award	2025-12-19	2025-12-19	35,000	—	$0	158,088	SEC↗
Hill Emily Luisa	Chief Financial Officer	A Award	2025-12-19	2025-12-19	60,000	—	$0	194,368	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award	2025-12-19	2025-12-19	60,000	—	$0	199,685	SEC↗
Patel Sushil	Chief Executive Officer	A Award	2025-12-19	2025-12-19	200,000	—	$0	533,576	SEC↗
Dhingra Kapil	Director	M Exercise deriv	2025-12-09	2025-12-11	3,169	—	$0	0	SEC↗
Dhingra Kapil	Director	M Exercise	2025-12-09	2025-12-11	3,169	$1.75	$5.5K	3,169	SEC↗
Dhingra Kapil	Director	S Sale	2025-12-09	2025-12-11	3,169	$10.40	$33.0K	0	SEC↗
Patel Sushil	Chief Executive Officer	S Sale	2025-12-02	2025-12-04	10,000	$11.13	$111.3K	333,576	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2025-11-17	2025-11-19	7,248	$9.10	$66.0K	139,685	SEC↗
Sarchi Christopher	Chief Commercial Officer	S Sale	2025-11-17	2025-11-19	5,208	$9.10	$47.4K	123,088	SEC↗
Hill Emily Luisa	Chief Financial Officer	S Sale	2025-08-15	2025-08-19	9,154	$5.37	$49.2K	134,368	SEC↗
Sarchi Christopher	Chief Commercial Officer	S Sale	2025-05-20	2025-05-22	3,749	$8.05	$30.2K	128,296	SEC↗
Hill Emily Luisa	Chief Financial Officer	S Sale	2025-05-20	2025-05-22	2,535	$8.05	$20.4K	143,522	SEC↗
Patel Sushil	Chief Executive Officer	S Sale	2025-05-20	2025-05-22	25,105	$8.06	$202.3K	343,576	SEC↗
Schwendenman Andrew	Chief Accounting Officer	S Sale	2025-05-20	2025-05-22	3,287	$8.05	$26.5K	68,284	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2025-05-20	2025-05-22	7,952	$8.06	$64.1K	146,933	SEC↗
Astley-Sparke Philip	Director	S Sale	2025-05-20	2025-05-22	32,279	$8.06	$260.2K	1,405,071	SEC↗
Schwendenman Andrew	Chief Accounting Officer	A Award deriv	2025-04-01	2025-04-03	50,000	—	$0	50,000	SEC↗
Oliger Christy J.	Director	A Award deriv	2025-04-01	2025-04-03	32,000	—	$0	32,000	SEC↗
Sarchi Christopher	Chief Commercial Officer	A Award deriv	2025-04-01	2025-04-03	67,500	—	$0	67,500	SEC↗
Weinand Dieter	Director	A Award deriv	2025-04-01	2025-04-03	32,000	—	$0	32,000	SEC↗
Hill Emily Luisa	Chief Financial Officer	A Award deriv	2025-04-01	2025-04-03	67,500	—	$0	67,500	SEC↗
SLATTERY JOSEPH P	Director	A Award deriv	2025-04-01	2025-04-03	32,000	—	$0	32,000	SEC↗
Dhingra Kapil	Director	A Award deriv	2025-04-01	2025-04-03	32,000	—	$0	32,000	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award deriv	2025-04-01	2025-04-03	67,500	—	$0	67,500	SEC↗
Balachandran Madhavan	Director	A Award deriv	2025-04-01	2025-04-03	32,000	—	$0	32,000	SEC↗
Pucci Paolo	Director	A Award deriv	2025-04-01	2025-04-03	32,000	—	$0	32,000	SEC↗
Patel Sushil	Chief Executive Officer	A Award deriv	2025-04-01	2025-04-03	250,000	—	$0	250,000	SEC↗
Peeples-Dyer Veleka	Director	A Award deriv	2025-04-01	2025-04-03	32,000	—	$0	32,000	SEC↗
Schwendenman Andrew	Chief Accounting Officer	A Award	2025-04-01	2025-04-03	33,333	—	$0	71,571	SEC↗
Sarchi Christopher	Chief Commercial Officer	A Award	2025-04-01	2025-04-03	45,000	—	$0	132,045	SEC↗
Hill Emily Luisa	Chief Financial Officer	A Award	2025-04-01	2025-04-03	45,000	—	$0	146,057	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award	2025-04-01	2025-04-03	45,000	—	$0	154,885	SEC↗
Patel Sushil	Chief Executive Officer	A Award	2025-04-01	2025-04-03	166,667	—	$0	368,681	SEC↗
Baker Bros. Advisors (GP) LLC	Director, 10% Owner	A Award deriv	2025-03-05	2025-03-07	64,000	—	$0	64,000	SEC↗
Baker Bros. Advisors (GP) LLC	Director, 10% Owner	A Award deriv	2025-03-05	2025-03-07	64,000	—	$0	64,000	SEC↗
Patel Sushil	Chief Executive Officer	S Sale	2024-12-16	2024-12-18	10,000	$12.42	$124.2K	202,014	SEC↗
Sarchi Christopher	Chief Commercial Officer	S Sale	2024-11-18	2024-11-20	5,207	$10.78	$56.1K	87,045	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2024-11-18	2024-11-20	7,246	$10.78	$78.1K	109,885	SEC↗
Balachandran Madhavan	Director	A Award deriv	2024-09-04	2024-09-05	64,000	—	$0	64,000	SEC↗
Astley-Sparke Philip	Executive Chairman	G Gift	2024-08-30	2024-08-30	50,000	—	$0	1,437,350	SEC↗
Hill Emily Luisa	Chief Financial Officer	S Sale	2024-08-16	2024-08-19	8,938	$10.18	$91.0K	101,057	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2024-06-07	2024-06-10	15,881	$7.50	$119.1K	117,131	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2024-05-16	2024-05-20	6,367	$6.47	$41.2K	133,012	SEC↗
Patel Sushil	Chief Executive Officer	S Sale	2024-05-16	2024-05-20	20,194	$6.47	$130.7K	212,014	SEC↗
Coffin Robert	Director	S Sale	2024-05-16	2024-05-20	11,464	$6.47	$74.2K	1,821,872	SEC↗
Astley-Sparke Philip	Executive Chairman	S Sale	2024-05-16	2024-05-20	37,928	$6.47	$245.4K	1,487,350	SEC↗
Love Colin	Chief Operating Officer	S Sale	2024-05-16	2024-05-20	17,615	$6.47	$114.0K	777,345	SEC↗
Schwendenman Andrew	Chief Accounting Officer	S Sale	2024-05-16	2024-05-20	2,298	$6.47	$14.9K	38,238	SEC↗
Sarchi Christopher	Chief Commercial Officer	S Sale	2024-05-16	2024-05-20	2,218	$6.47	$14.4K	92,252	SEC↗
Schwendenman Andrew	Chief Accounting Officer	A Award deriv	2024-04-01	2024-04-03	53,325	—	$0	53,325	SEC↗
Levitsky Hyam	Director	A Award deriv	2024-04-01	2024-04-03	32,000	—	$0	32,000	SEC↗
Oliger Christy J.	Director	A Award deriv	2024-04-01	2024-04-03	32,000	—	$0	32,000	SEC↗
Sarchi Christopher	Chief Commercial Officer	A Award deriv	2024-04-01	2024-04-03	66,675	—	$0	66,675	SEC↗
Weinand Dieter	Director	A Award deriv	2024-04-01	2024-04-03	32,000	—	$0	32,000	SEC↗
SLATTERY JOSEPH P	Director	A Award deriv	2024-04-01	2024-04-03	32,000	—	$0	32,000	SEC↗
Hill Emily Luisa	Chief Financial Officer	A Award deriv	2024-04-01	2024-04-03	80,000	—	$0	80,000	SEC↗
Dhingra Kapil	Director	A Award deriv	2024-04-01	2024-04-03	32,000	—	$0	32,000	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award deriv	2024-04-01	2024-04-03	80,000	—	$0	80,000	SEC↗
Pucci Paolo	Director	A Award deriv	2024-04-01	2024-04-03	32,000	—	$0	32,000	SEC↗
Patel Sushil	Chief Executive Officer	A Award deriv	2024-04-01	2024-04-03	250,000	—	$0	250,000	SEC↗
Peeples-Dyer Veleka	Director	A Award deriv	2024-04-01	2024-04-03	32,000	—	$0	32,000	SEC↗
Schwendenman Andrew	Chief Accounting Officer	A Award	2024-04-01	2024-04-03	17,775	—	$0	40,536	SEC↗
Sarchi Christopher	Chief Commercial Officer	A Award	2024-04-01	2024-04-03	22,225	—	$0	94,470	SEC↗
Hill Emily Luisa	Chief Financial Officer	A Award	2024-04-01	2024-04-03	26,665	—	$0	109,995	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award	2024-04-01	2024-04-03	26,665	—	$0	139,379	SEC↗
Patel Sushil	Chief Executive Officer	A Award	2024-04-01	2024-04-03	83,335	—	$0	232,208	SEC↗
Sarchi Christopher	Chief Commercial Officer	S Sale	2023-11-16	2023-11-17	5,255	$10.92	$57.4K	72,245	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2023-11-16	2023-11-17	7,313	$10.92	$79.9K	112,714	SEC↗
Hill Emily Luisa	Chief Financial Officer	A Award deriv	2023-09-18	2023-09-20	125,000	—	$0	125,000	SEC↗
Hill Emily Luisa	Chief Financial Officer	A Award	2023-09-18	2023-09-20	83,330	—	$0	83,330	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2023-09-12	2023-09-13	300	—	$0	86,033	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2023-09-12	2023-09-13	300	$3.30	$990	263,736	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2023-09-12	2023-09-13	300	$20.00	$6.0K	263,436	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2023-09-11	2023-09-13	5,358	—	$0	86,333	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2023-09-11	2023-09-13	5,358	$20.01	$107.2K	263,436	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2023-09-11	2023-09-13	5,358	$3.30	$17.7K	268,794	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2023-08-22	2023-08-24	5,000	—	$0	35,750	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2023-08-22	2023-08-24	13,600	—	$0	91,691	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2023-08-22	2023-08-24	18,600	$20.01	$372.2K	263,436	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2023-08-22	2023-08-24	5,000	$15.50	$77.5K	282,036	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2023-08-22	2023-08-24	13,600	$3.30	$44.9K	277,036	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2023-08-11	2023-08-15	1,400	—	$0	105,291	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2023-08-11	2023-08-15	1,400	$20.00	$28.0K	263,436	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2023-08-11	2023-08-15	1,400	$3.30	$4.6K	264,836	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2023-07-10	2023-07-11	15,000	—	$0	106,691	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2023-07-10	2023-07-11	5,000	—	$0	40,750	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2023-07-10	2023-07-11	2,077	$21.12	$43.9K	263,436	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2023-07-10	2023-07-11	15,000	$3.30	$49.5K	278,436	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2023-07-10	2023-07-11	5,000	$15.50	$77.5K	283,436	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2023-07-10	2023-07-11	17,923	$21.63	$387.7K	265,513	SEC↗
Patel Sushil	Chief Strategy Officer	S Sale	2023-06-13	2023-06-15	553	$23.44	$13.0K	148,873	SEC↗
Patel Sushil	Chief Strategy Officer	S Sale	2023-06-13	2023-06-15	5,145	$24.11	$124.0K	149,426	SEC↗
Lewis Tanya	Chief Dev. Op. Officer	S Sale	2023-06-13	2023-06-15	817	$23.45	$19.2K	135,293	SEC↗
Lewis Tanya	Chief Dev. Op. Officer	S Sale	2023-06-13	2023-06-15	12,043	$24.10	$290.2K	136,110	SEC↗
Peeples-Dyer Veleka	Director	A Award deriv	2023-06-01	2023-06-05	50,400	—	$0	50,400	SEC↗
Astley-Sparke Philip	Chief Executive Officer	S Sale	2023-05-16	2023-05-18	17,902	$18.05	$323.1K	1,525,278	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2023-05-16	2023-05-18	5,966	$18.05	$107.7K	263,436	SEC↗
Xynos Konstantinos	Chief Medical Officer	S Sale	2023-05-16	2023-05-18	771	$18.05	$13.9K	120,027	SEC↗
Franchi Jean M.	Chief Financial Officer	S Sale	2023-05-16	2023-05-18	11,351	$18.05	$204.9K	128,748	SEC↗
Love Colin	Chief Operating Officer	S Sale	2023-05-16	2023-05-18	10,775	$18.05	$194.5K	794,960	SEC↗
Lewis Tanya	Chief Dev. Op. Officer	S Sale	2023-05-16	2023-05-18	12,207	$18.05	$220.3K	148,153	SEC↗
Coffin Robert	President & Chief R&D Office	S Sale	2023-05-16	2023-05-18	7,861	$18.05	$141.9K	1,833,336	SEC↗
Patel Sushil	Chief Strategy Officer	S Sale	2023-05-16	2023-05-18	15,575	$18.05	$281.1K	154,571	SEC↗
Astley-Sparke Philip	Chief Executive Officer	A Award deriv	2023-04-01	2023-04-04	213,150	—	$0	213,150	SEC↗
Coffin Robert	President & Chief R&D Office	A Award deriv	2023-04-01	2023-04-04	67,500	—	$0	67,500	SEC↗
Patel Sushil	Chief Strategy Officer	A Award deriv	2023-04-01	2023-04-04	60,000	—	$0	60,000	SEC↗
Lewis Tanya	Chief Dev. Op. Officer	A Award deriv	2023-04-01	2023-04-04	60,000	—	$0	60,000	SEC↗
Love Colin	Chief Operating Officer	A Award deriv	2023-04-01	2023-04-04	60,000	—	$0	60,000	SEC↗
Franchi Jean M.	Chief Financial Officer	A Award deriv	2023-04-01	2023-04-04	67,500	—	$0	67,500	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award deriv	2023-04-01	2023-04-04	75,000	—	$0	75,000	SEC↗
Esposito Pamela	Chief Business Officer	A Award deriv	2023-04-01	2023-04-04	60,000	—	$0	60,000	SEC↗
Oliger Christy J.	Director	A Award deriv	2023-04-01	2023-04-04	25,200	—	$0	25,200	SEC↗
Weinand Dieter	Director	A Award deriv	2023-04-01	2023-04-04	37,800	—	$0	37,800	SEC↗
Levitsky Hyam	Director	A Award deriv	2023-04-01	2023-04-04	25,200	—	$0	25,200	SEC↗
SLATTERY JOSEPH P	Director	A Award deriv	2023-04-01	2023-04-04	25,200	—	$0	25,200	SEC↗
Dhingra Kapil	Director	A Award deriv	2023-04-01	2023-04-04	25,200	—	$0	25,200	SEC↗
Pucci Paolo	Director	A Award deriv	2023-04-01	2023-04-04	25,200	—	$0	25,200	SEC↗
Slootweg Hugo Alexander	Director	A Award deriv	2023-04-01	2023-04-04	25,200	—	$0	25,200	SEC↗
Astley-Sparke Philip	Chief Executive Officer	A Award	2023-04-01	2023-04-04	142,100	—	$0	1,543,180	SEC↗
Coffin Robert	President & Chief R&D Office	A Award	2023-04-01	2023-04-04	45,000	—	$0	1,841,197	SEC↗
Patel Sushil	Chief Strategy Officer	A Award	2023-04-01	2023-04-04	40,000	—	$0	170,146	SEC↗
Lewis Tanya	Chief Dev. Op. Officer	A Award	2023-04-01	2023-04-04	40,000	—	$0	160,360	SEC↗
Love Colin	Chief Operating Officer	A Award	2023-04-01	2023-04-04	40,000	—	$0	805,735	SEC↗
Franchi Jean M.	Chief Financial Officer	A Award	2023-04-01	2023-04-04	45,000	—	$0	140,099	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award	2023-04-01	2023-04-04	50,000	—	$0	120,798	SEC↗
Esposito Pamela	Chief Business Officer	A Award	2023-04-01	2023-04-04	40,000	—	$0	269,402	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2022-12-09	2022-12-13	15,000	—	$0	36,203	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2022-12-09	2022-12-13	15,000	$25.03	$375.4K	229,402	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2022-12-09	2022-12-13	15,000	$1.01	$15.2K	244,402	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award deriv	2022-12-01	2022-12-05	26,250	—	$0	26,250	SEC↗
Xynos Konstantinos	Chief Medical Officer	A Award	2022-12-01	2022-12-05	17,500	—	$0	70,798	SEC↗
Astley-Sparke Philip	Chief Executive Officer	S Sale	2022-05-16	2022-05-18	9,632	$14.59	$140.5K	1,401,080	SEC↗
Coffin Robert	President & Chief R&D Office	S Sale	2022-05-16	2022-05-18	5,737	$14.59	$83.7K	1,796,197	SEC↗
Patel Sushil	Chief Commercial Officer	S Sale	2022-05-16	2022-05-18	10,687	$14.59	$155.9K	130,146	SEC↗
Lewis Tanya	Chief Dev. Op Officer	S Sale	2022-05-16	2022-05-18	5,473	$14.59	$79.9K	120,360	SEC↗
Franchi Jean M.	Chief Financial Officer	S Sale	2022-05-16	2022-05-18	3,436	$14.59	$50.1K	95,099	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2022-05-16	2022-05-18	3,507	$14.59	$51.2K	229,402	SEC↗
Love Colin	Chief Operating Officer	S Sale	2022-05-16	2022-05-18	6,324	$14.59	$92.3K	765,735	SEC↗
Oliger Christy J.	Director	A Award deriv	2022-04-01	2022-04-05	16,500	—	$0	16,500	SEC↗
Levitsky Hyam	Director	A Award deriv	2022-04-01	2022-04-05	16,500	—	$0	16,500	SEC↗
Pucci Paolo	Director	A Award deriv	2022-04-01	2022-04-05	16,500	—	$0	16,500	SEC↗
Slootweg Hugo Alexander	Director	A Award deriv	2022-04-01	2022-04-05	16,500	—	$0	16,500	SEC↗
Weinand Dieter	Director	A Award deriv	2022-04-01	2022-04-05	24,750	—	$0	24,750	SEC↗
SLATTERY JOSEPH P	Director	A Award deriv	2022-04-01	2022-04-05	16,500	—	$0	16,500	SEC↗
Dhingra Kapil	Director	A Award deriv	2022-04-01	2022-04-05	16,500	—	$0	16,500	SEC↗
Rhodes Jason P	Director	A Award deriv	2022-04-01	2022-04-05	16,500	—	$0	16,500	SEC↗
Love Colin	Chief Operating Officer	A Award deriv	2022-04-01	2022-04-05	39,375	—	$0	39,375	SEC↗
Esposito Pamela	Chief Business Officer	A Award deriv	2022-04-01	2022-04-05	34,125	—	$0	34,125	SEC↗
Lewis Tanya	Chief Dev.Op Off	A Award deriv	2022-04-01	2022-04-05	78,750	—	$0	78,750	SEC↗
Patel Sushil	Chief Commercial Officer	A Award deriv	2022-04-01	2022-04-05	78,750	—	$0	78,750	SEC↗
Franchi Jean M.	Chief Financial Officer	A Award deriv	2022-04-01	2022-04-05	78,750	—	$0	78,750	SEC↗
Coffin Robert	President & Chief R&D Office	A Award deriv	2022-04-01	2022-04-05	39,375	—	$0	39,375	SEC↗
Astley-Sparke Philip	Chief Executive Officer	A Award deriv	2022-04-01	2022-04-05	105,000	—	$0	105,000	SEC↗
Love Colin	Chief Operating Officer	A Award	2022-04-01	2022-04-05	26,250	—	$0	772,059	SEC↗
Esposito Pamela	Chief Business Officer	A Award	2022-04-01	2022-04-05	22,750	—	$0	232,909	SEC↗
Lewis Tanya	Chief Dev.Op Off	A Award	2022-04-01	2022-04-05	52,500	—	$0	125,833	SEC↗
Patel Sushil	Chief Commercial Officer	A Award	2022-04-01	2022-04-05	52,500	—	$0	140,833	SEC↗
Franchi Jean M.	Chief Financial Officer	A Award	2022-04-01	2022-04-05	52,500	—	$0	98,535	SEC↗
Coffin Robert	President & Chief R&D Office	A Award	2022-04-01	2022-04-05	26,250	—	$0	1,801,934	SEC↗
Astley-Sparke Philip	Chief Executive Officer	A Award	2022-04-01	2022-04-05	70,000	—	$0	1,410,712	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2022-03-16	2022-03-16	38,762	$15.55	$602.7K	4,673,380	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2022-03-16	2022-03-16	6,238	$15.31	$95.5K	4,712,142	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2022-03-15	2022-03-16	45,000	$15.64	$703.8K	4,718,380	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	M Exercise deriv	2022-03-14	2022-03-16	16,500	—	$0	16,500	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2022-03-14	2022-03-16	16,500	$15.42	$254.4K	4,763,380	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	M Exercise	2022-03-14	2022-03-16	16,500	$9.78	$161.4K	4,779,880	SEC↗
Oliger Christy J.	Director	A Award deriv	2021-12-01	2021-12-03	33,000	—	$0	33,000	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-22	2021-11-23	10,162	$34.70	$352.6K	4,763,380	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-19	2021-11-23	34,845	$34.54	$1.20M	4,773,959	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-19	2021-11-23	417	$34.80	$14.5K	4,773,542	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-18	2021-11-18	2,441	$33.50	$81.8K	4,808,804	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2021-11-18	2021-11-18	2,441	$33.50	$81.8K	4,808,804	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-16	2021-11-18	153	$33.50	$5.1K	4,811,245	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2021-11-16	2021-11-18	153	$33.50	$5.1K	4,811,245	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-15	2021-11-16	782	$33.66	$26.3K	4,811,398	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-12	2021-11-16	23,235	$33.66	$782.1K	4,812,180	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-11	2021-11-12	18,279	$33.61	$614.4K	4,835,415	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-10	2021-11-12	11	$33.50	$369	4,853,694	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-09	2021-11-10	7,537	$33.73	$254.2K	4,853,705	SEC↗
Omega Fund IV GP, L.P.	10% Owner	S Sale	2021-11-08	2021-11-10	3,817	$33.53	$128.0K	4,861,242	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2021-11-05	2021-11-08	5,790	$33.50	$194.0K	4,865,059	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2021-11-04	2021-11-08	25,225	$33.58	$847.1K	4,870,849	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-10-18	2021-10-19	12,711	$29.58	$376.0K	745,809	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-10-15	2021-10-19	15,089	$30.31	$457.3K	758,520	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-10-15	2021-10-19	2,200	$31.16	$68.6K	773,609	SEC↗
Stampacchia Otello	Director, 10% Owner	S Sale	2021-09-23	2021-09-27	12,171	$33.58	$408.7K	4,896,074	SEC↗
Omega Fund IV, L.P.	Director, 10% Owner	S Sale	2021-09-17	2021-09-20	15,465	$33.71	$521.3K	4,908,245	SEC↗
Omega Fund IV, L.P.	Director, 10% Owner	S Sale	2021-09-17	2021-09-20	78,998	$32.88	$2.60M	4,923,710	SEC↗
Omega Fund IV, L.P.	Director, 10% Owner	S Sale	2021-09-16	2021-09-20	5,537	$32.55	$180.2K	5,002,708	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-09-15	2021-09-17	30,000	$31.23	$936.9K	775,809	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-08-16	2021-08-18	2,700	$29.27	$79.0K	805,809	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-08-16	2021-08-18	27,300	$30.00	$819.0K	808,509	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2021-08-05	2021-08-06	25,800	—	$0	45,750	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2021-08-05	2021-08-06	25,800	$35.09	$905.3K	210,159	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2021-08-05	2021-08-06	25,800	$15.50	$399.9K	235,959	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2021-08-04	2021-08-06	4,200	—	$0	71,550	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2021-08-04	2021-08-06	4,200	$35.00	$147.0K	210,159	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2021-08-04	2021-08-06	4,200	$15.50	$65.1K	214,359	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2021-07-21	2021-07-22	12,538	—	$0	51,203	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2021-07-21	2021-07-22	12,538	$1.01	$12.7K	222,697	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2021-07-21	2021-07-22	12,538	$33.17	$415.9K	210,159	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2021-07-20	2021-07-22	4,862	—	$0	63,741	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2021-07-20	2021-07-22	4,862	$33.05	$160.7K	210,159	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2021-07-20	2021-07-22	4,862	$1.01	$4.9K	215,021	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise deriv	2021-07-15	2021-07-19	4,600	—	$0	68,603	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-07-15	2021-07-16	30,000	$32.02	$960.6K	835,809	SEC↗
Esposito Pamela	Chief Business Officer	S Sale	2021-07-15	2021-07-19	4,600	$33.37	$153.5K	210,159	SEC↗
Esposito Pamela	Chief Business Officer	M Exercise	2021-07-15	2021-07-19	4,600	$1.01	$4.6K	214,759	SEC↗
Coffin Robert	President & Chief R&D Office	S Sale	2021-07-02	2021-07-07	7,810	$40.04	$312.7K	1,775,684	SEC↗
Coffin Robert	President & Chief R&D Office	S Sale	2021-06-29	2021-06-30	22,826	$40.05	$914.2K	1,783,494	SEC↗
Coffin Robert	President & Chief R&D Office	S Sale	2021-06-28	2021-06-30	14,663	$40.04	$587.1K	1,806,320	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-06-15	2021-06-16	12,200	$34.53	$421.3K	865,809	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-06-15	2021-06-16	17,800	$33.80	$601.6K	878,009	SEC↗
Lewis Tanya	Chief Dev. Oper. Off.	A Award deriv	2021-05-10	2021-05-11	110,000	—	$0	110,000	SEC↗
Lewis Tanya	Chief Dev. Oper. Off.	A Award	2021-05-10	2021-05-11	73,333	—	$0	73,333	SEC↗
Patel Sushil	Chief Commercial Officer	A Award deriv	2021-05-03	2021-05-05	125,000	—	$0	125,000	SEC↗
Patel Sushil	Chief Commercial Officer	A Award	2021-05-03	2021-05-05	88,333	—	$0	88,333	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-04-15	2021-04-19	27,300	$30.69	$837.8K	898,509	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-04-15	2021-04-19	2,700	$29.98	$80.9K	895,809	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	A Award deriv	2021-04-01	2021-04-05	16,500	—	$0	16,500	SEC↗
Dhingra Kapil	Director	A Award deriv	2021-04-01	2021-04-05	16,500	—	$0	16,500	SEC↗
SLATTERY JOSEPH P	Director	A Award deriv	2021-04-01	2021-04-05	16,500	—	$0	16,500	SEC↗
Slootweg Hugo Alexander	Director	A Award deriv	2021-04-01	2021-04-05	16,500	—	$0	16,500	SEC↗
Weinand Dieter	Director	A Award deriv	2021-04-01	2021-04-05	24,750	—	$0	24,750	SEC↗
Pucci Paolo	Director	A Award deriv	2021-04-01	2021-04-05	16,500	—	$0	16,500	SEC↗
Lewis Tanya	Director	A Award deriv	2021-04-01	2021-04-05	16,500	—	$0	16,500	SEC↗
Levitsky Hyam	Director	A Award deriv	2021-04-01	2021-04-05	16,500	—	$0	16,500	SEC↗
Rhodes Jason P	Director	A Award deriv	2021-04-01	2021-04-05	16,500	—	$0	16,500	SEC↗
Love Colin	Chief Operating Officer	A Award deriv	2021-04-01	2021-04-05	58,925	—	$0	58,925	SEC↗
Astley-Sparke Philip	Chief Executive Officer	A Award deriv	2021-04-01	2021-04-05	128,125	—	$0	128,125	SEC↗
Coffin Robert	President & Chief R&D Office	A Award deriv	2021-04-01	2021-04-05	115,300	—	$0	115,300	SEC↗
Franchi Jean M.	Chief Financial Officer	A Award deriv	2021-04-01	2021-04-05	69,050	—	$0	69,050	SEC↗
Pirzkall Andrea	Chief Medical Officer	A Award deriv	2021-04-01	2021-04-05	30,750	—	$0	30,750	SEC↗
Esposito Pamela	Chief Business Officer	A Award deriv	2021-04-01	2021-04-05	51,250	—	$0	51,250	SEC↗
Love Colin	Chief Operating Officer	A Award	2021-04-01	2021-04-05	39,285	—	$0	925,809	SEC↗
Astley-Sparke Philip	Chief Executive Officer	A Award	2021-04-01	2021-04-05	85,415	—	$0	1,340,712	SEC↗
Coffin Robert	President & Chief R&D Office	A Award	2021-04-01	2021-04-05	76,865	—	$0	1,820,983	SEC↗
Franchi Jean M.	Chief Financial Officer	A Award	2021-04-01	2021-04-05	46,035	—	$0	46,035	SEC↗
Pirzkall Andrea	Chief Medical Officer	A Award	2021-04-01	2021-04-05	20,500	—	$0	21,500	SEC↗
Esposito Pamela	Chief Business Officer	A Award	2021-04-01	2021-04-05	34,165	—	$0	210,159	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-03-15	2021-03-17	18,518	$33.22	$615.2K	886,624	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-03-15	2021-03-17	100	$32.67	$3.3K	886,524	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-03-15	2021-03-17	11,382	$34.06	$387.7K	905,142	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-02-16	2021-02-18	18,620	$36.61	$681.7K	927,904	SEC↗
Love Colin	Chief Operating Officer	S Sale	2021-02-16	2021-02-18	11,380	$35.84	$407.9K	916,524	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2021-02-08	2021-02-11	5,249	$45.00	$236.2K	5,141,321	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2021-01-26	2021-01-28	3,393	$46.04	$156.2K	5,283,682	SEC↗
Omega Fund IV G.P. Manager, Lt	10% Owner	S Sale	2021-01-26	2021-01-28	26,957	$45.34	$1.22M	5,287,075	SEC↗
Rhodes Jason P	Director	S Sale	2021-01-26	2021-01-28	5,558	$46.14	$256.4K	946,000	SEC↗
Stampacchia Otello	Director, 10% Owner	S Sale	2021-01-22	2021-01-26	8,090	$45.05	$364.5K	5,317,301	SEC↗
Stampacchia Otello	Director, 10% Owner	S Sale	2021-01-22	2021-01-26	3,269	$45.03	$147.2K	5,314,032	SEC↗
Coffin Robert	President & Chief R&D Office	S Sale	2021-01-22	2021-01-26	29,803	$43.99	$1.31M	1,744,118	SEC↗